Back to Search Start Over

SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study

Authors :
Gilbert Greub
Giuseppe Pantaleo
Oriol Manuel
Urania Dafni
Valérie D'Acremont
Estelle Moulin
Bruno Grandbastien
Thierry Calandra
Sylvain Meylan
Frederic Lamoth
Zoi Tsourti
Michael A Lobritz
Jean Regina
Philippe Bressin
Laurence Senn
Cyril Andre
Craig Fenwick
Antony Croxatto
Isabelle Guilleret
Catherine Lazor-Blanchet
Oliver Peters
Michael Currat
Laurence Posset
Fady Fares
Vassili Soumas
Séverine Bignon
Elisa Corne
Joana Da Silva Quelhas
Allan Dussex
Dominique Ker
Patricia Mosset
Eugénie Prouvost
Kyllian Ruscio
Sandrine Piccon
Fleur Valterio
Emilie Allain
Charles Guay
Zahra Hezari
Yoann Levet
Marie-Agnès Prevost
Adeline Rognon
Homa Salehi-Gysel
Cécile Starck
Aurélie Tornier
Sara Torres da Fonseca
Aline Udriot
COVID-19 MISS group
Peters, O.
Currat, M.
Posset, L.
Fares, F.
Soumas, V.
Bignon, S.
Corne, E.
Quelhas, JDS
Dussex, A.
Ker, D.
Mosset, P.
Moulin, E.
Prouvost, E.
Ruscio, K.
Piccon, S.
Valterio, F.
Allain, E.
Guay, C.
Hezari, Z.
Levet, Y.
Prevost, M.A.
Rognon, A.
Salehi-Gysel, H.
Starck, C.
Tornier, A.
da Fonseca, S.T.
Udriot, A.
Source :
BMJ Open, BMJ Open, Vol 11, Iss 7 (2021), BMJ open, vol. 11, no. 7, pp. e049232
Publication Year :
2021

Abstract

ObjectiveTo assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure.DesignSeroprevalence cross-sectional study.SettingSingle centre at the end of the first COVID-19 wave in Lausanne, Switzerland.Participants1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs.Main outcome measuresEvaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisition risk factors internal and external to the workplace.ResultsThe overall SARS-CoV-2 seroprevalence rate among HCWs was 10.0% (95% CI 8.7% to 11.5%). HCWs with daily patient contact did not experience increased rates of seropositivity relative to those without (10.3% vs 9.6%, respectively, p=0.64). HCWs with direct contact with patients with COVID-19 or working in COVID-19 units did not experience increased seropositivity rates relative to their counterparts (10.4% vs 9.8%, p=0.69 and 10.6% vs 9.9%, p=0.69, respectively). However, specific locations of contact with patients irrespective of COVID-19 status—in patient rooms or reception areas—did correlate with increased rates of seropositivity (11.9% vs 7.5%, p=0.019 and 14.3% vs 9.2%, p=0.025, respectively). In contrast, HCWs with a suspected or proven SARS-CoV-2-infected household contact had significantly higher seropositivity rates than those without such contacts (19.0% vs 8.7%, pConclusionsThe overall seroprevalence was 10% without significant differences in seroprevalence between HCWs exposed to patients with COVID-19 and HCWs not exposed. This suggests that, once fully in place, protective measures limited SARS-CoV-2 occupational acquisition within the hospital environment. SARS-CoV-2 seroconversion among HCWs was associated primarily with community risk factors, particularly household transmission.

Details

ISSN :
20446055
Volume :
11
Issue :
7
Database :
OpenAIRE
Journal :
BMJ open
Accession number :
edsair.doi.dedup.....3a3b8c64bebf01f3fc366142bfdb88f5